{
  "paper_metadata": {
    "pmid": "33619265",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.778_779del",
      "protein_notation": "p.E260fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "50 years old, female",
        "phenotype": "BRCA2-driven breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal carcinoma",
          "evidence_sentence": "Germline testing revealed a pathogenic BRCA2 germline alteration."
        }
      ],
      "functional_data": {
        "summary": "The alteration leads to a frameshift mutation.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is associated with a high risk of breast cancer.",
      "key_quotes": [
        "Germline testing revealed a pathogenic BRCA2 germline alteration."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.764_770del",
      "protein_notation": "p.N255fs",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "50 years old, female",
        "phenotype": "BRCA2-driven breast cancer with resistance to PARP inhibitors"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "developed resistance to PARP inhibitor olaparib",
          "evidence_sentence": "This somatic alteration (p.N255fs, c.764_770del) in combination with the germline frameshift resulted in an in-frame indel and subsequent restoration of the BRCA2 reading frame."
        }
      ],
      "functional_data": {
        "summary": "The alteration restores the open reading frame, likely accounting for resistance to PARP inhibition.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 6",
      "additional_notes": "This variant is associated with acquired resistance to treatment.",
      "key_quotes": [
        "This somatic alteration (p.N255fs, c.764_770del) in combination with the germline frameshift resulted in an in-frame indel and subsequent restoration of the BRCA2 reading frame."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.755_758del",
      "protein_notation": "p.D252fs",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "50 years old, female",
        "phenotype": "BRCA2-driven breast cancer with resistance to PARP inhibitors"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "developed resistance to PARP inhibitor olaparib",
          "evidence_sentence": "The genomic analysis identified the known somatic and germline BRCA2 alterations (1% and 53.4% VAF, respectively), as well as an additional unique somatic BRCA2 alteration (p.D252fs, c.755_758del) at 0.9% VAF."
        }
      ],
      "functional_data": {
        "summary": "The alteration restores the open reading frame, likely accounting for resistance to PARP inhibition.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 8",
      "additional_notes": "This variant is associated with acquired resistance to treatment.",
      "key_quotes": [
        "The genomic analysis identified the known somatic and germline BRCA2 alterations (1% and 53.4% VAF, respectively), as well as an additional unique somatic BRCA2 alteration (p.D252fs, c.755_758del) at 0.9% VAF."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}